Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 7.13
- Piotroski Score 6.00
- Grade Neutral
- Symbol (NEWR)
- Company New Relic, Inc.
- Price $86.99
- Changes Percentage (0.02%)
- Change $0.02
- Day Low $86.97
- Day High $87.01
- Year High $87.01
New Relic, Inc., a software-as-a-service company, delivers a software platform for customers to collect telemetry data and derive insights from that data in a unified front-end application. It offers a suite of products on its open and extensible cloud-based platform, which enables users to collect, store, and analyze telemetry data. The company's platform also provides New Relic Instant Observability, an open-source ecosystem of quickstarts that delivers pre-built integrations, dashboards, and alerts for approximately 450 technologies and frameworks; and supports custom app development through common open-source frameworks, a library of existing applications, and a development environment. It sells its products through direct sales organizations, and online and offline sales in the United States and internationally. New Relic, Inc. was founded in 2007 and is headquartered in San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/04/2024
- Fiscal Year End N/A
- Average Stock Price Target $77.50
- High Stock Price Target $150.00
- Low Stock Price Target $55.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.09
- Trailing P/E Ratio -41.622009569378
- Forward P/E Ratio -41.622009569378
- P/E Growth -41.622009569378
- Net Income $-178,827,000
Income Statement
Quarterly
Annual
Latest News of NEWR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
We Might See A Profit From Newron Pharmaceuticals S.p.A. (VTX:NWRN) Soon
Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focusing on CNS and pain treatments. Analysts predict the company will break even in 2024, with a projected 51% annual growth rate. Despite...
By Yahoo! Finance | 1 month ago
